Longevity Club
Sign in

HBOT Reduced My Dementia-Risk Marker by 28%

ByBryan JohnsonBlueprintLongevityMetabolic health

Hi Friend,

HBOT (Hyperbaric Oxygen Therapy) reduced a dementia-risk marker of mine by 28%.

Details

  • pTAU217 just got FDA-cleared for early Alzheimer's screening. It also has prognostic value for healthy brains.

  • The FDA just approved the pTAU217/Aβ42 ratio as the first blood test for the early detection of Alzheimer's disease.

  • HBOT reduced my pTAU217 level by 28%.

  • A recent study also confirmed p-TAU217 as a marker of future dementia risk in healthy people.

Read the full blog post

──

Bryan

Disclaimer: this email is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Originally published in Bryan Johnson's Blueprint newsletter (June 5, 2025). This content is for informational purposes only and is not medical advice.